论文部分内容阅读
目的: 分析晚期恶性肿瘤患者血糖变化及其对病情和预后的影响。方法: 按成活与死亡两种转归分组,比较两组血糖异常率及变化幅度;同时按血糖正常和异常( 升高或降低) 情况,比较其病死率与好转率的差别。结果:死亡组血糖异常率为51.7% ,存活组为22.6 % ,两组有极显著性差异( P< 0.01) 。死亡组血糖升高或降低程度也较存活组严重;血糖异常患者病死率(68.2 % ) 显著高于血糖正常者(36.8% ,P< 0.01) 。结论:晚期恶性肿瘤患者血糖水平的变化对判断病情和预后有重要临床意义
Objective: To analyze the changes of blood glucose and its influence on the condition and prognosis of patients with advanced malignant tumors. Methods: According to the survival and death of the two groups, compare the two groups of blood glucose abnormalities and the extent of change; at the same time, according to the normal and abnormal blood glucose (elevated or reduced), compare the mortality and the improvement rate of the difference. Results: The abnormal rate of blood glucose was 51.7% in the death group and 22.6% in the survival group. There was a significant difference between the two groups (P<0.01). The degree of blood glucose increase or decrease in the death group was also greater than that in the survival group; the mortality rate of patients with abnormal blood glucose (68.2%) was significantly higher than those with normal blood glucose (36.8%, P<0.01). Conclusion: The changes of blood glucose levels in patients with advanced malignant tumors have important clinical significance for judging the condition and prognosis